Potential conflict of interest: Nothing to report.
Epigenetic reprogramming modulates malignant properties of human liver cancer
Version of Record online: 1 MAY 2014
Published 2014. This article is a U.S. Government work and is in the public domain in the USA.
Volume 59, Issue 6, pages 2251–2262, June 2014
How to Cite
Raggi, C., Factor, V. M., Seo, D., Holczbauer, A., Gillen, M. C., Marquardt, J. U., Andersen, J. B., Durkin, M. and Thorgeirsson, S. S. (2014), Epigenetic reprogramming modulates malignant properties of human liver cancer. Hepatology, 59: 2251–2262. doi: 10.1002/hep.27026
Supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.
- Issue online: 28 MAY 2014
- Version of Record online: 1 MAY 2014
- Accepted manuscript online: 21 JAN 2014 09:12AM EST
- Manuscript Accepted: 15 JAN 2014
- Manuscript Revised: 6 JAN 2014
- Manuscript Received: 10 JUL 2013
Additional Supporting Information may be found in the online version of this article at the publisher's website.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.